J Am Dent Assoc. 2020 Apr;151(4):303-304.e2. doi: 10.1016/j.adaj.2020.01.027.
Human papillomavirus (HPV) is a sexually transmitted oncovirus associated with several malignancies, including oropharyngeal squamous cell carcinoma. The 9-valent HPV vaccine can help protect against the high-risk HPV strains most commonly associated with HPV-related cancers.
The authors used an electronic survey to assess the roles of dentists and their team members in discussing the HPV vaccine, as well as administering the vaccine in a dental setting. On December 6, 2019, the authors e-mailed a survey link to the American Dental Association Clinical Evaluators (ACE) Panel (n = 813), a sample of American Dental Association member dentists. After 1 e-mail reminder, the survey closed on December 19, 2019, and the authors conducted exploratory and descriptive data analyses using SAS Version 9.4 (SAS).
A total of 329 dentists responded to the survey, and 83 (25%) of them reported that they or their team members discuss the implications of the HPV vaccine with age-eligible patients or their parents or guardians. Dentists lead two-thirds (n = 218) of the discussions, and the clinical examination is the most frequent moment during the patient visit in which HPV-related topics are discussed. Some of the top reasons respondents mentioned for not discussing the vaccine in their practice were the perception that these discussions are best left to other health care professionals and not knowing how to address the topic with patients. If the scope of dental practice is expanded to include administering the vaccine, 125 (38%) of respondents would feel uncomfortable administering the vaccine. The most common potential barriers to administering the vaccine in a dental setting include obtaining reimbursement and vaccine management and preservation.
The survey results suggest that dentists' comfort levels and perceived roles in discussing and administering the HPV vaccine vary.
There is a need to further define the role of dentists and their team members in the promotion and administration of the HPV vaccine. Resources for dentists and dental team members may be helpful to support professional education and communication about the HPV vaccine.
人乳头瘤病毒（HPV）是一种性传播的致癌病毒，与多种恶性肿瘤有关，包括口咽鳞状细胞癌。九价 HPV 疫苗有助于预防与 HPV 相关癌症最常见的高危 HPV 株。
作者使用电子调查评估了牙医及其团队成员在讨论 HPV 疫苗以及在牙科环境中接种疫苗方面的作用。2019 年 12 月 6 日，作者向美国牙科协会临床评估员（ACE）小组（n=813）的成员牙医发送了一份调查链接。在发出 1 次电子邮件提醒后，调查于 2019 年 12 月 19 日结束，作者使用 SAS 版本 9.4（SAS）进行了探索性和描述性数据分析。
共有 329 名牙医对调查做出了回应，其中 83 名（25%）报告说，他们或他们的团队成员与符合年龄条件的患者或其父母或监护人讨论 HPV 疫苗的影响。牙医主导了三分之二（n=218）的讨论，临床检查是患者就诊时讨论 HPV 相关话题最频繁的时刻。受访者提到在实践中不讨论疫苗的一些主要原因是，他们认为这些讨论最好由其他医疗保健专业人员进行，并且不知道如何与患者讨论这个话题。如果扩大牙科实践的范围以包括接种疫苗，如果扩大牙科实践的范围以包括接种疫苗，125 名（38%）受访者会感到不舒服接种疫苗。在牙科环境中接种疫苗的最常见潜在障碍包括获得报销以及疫苗管理和保存。
调查结果表明，牙医在讨论和接种 HPV 疫苗方面的舒适度和感知角色存在差异。
需要进一步确定牙医及其团队成员在推广和管理 HPV 疫苗方面的作用。为牙医和牙科团队成员提供资源可能有助于支持关于 HPV 疫苗的专业教育和沟通。
